Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166711075> ?p ?o ?g. }
- W2166711075 endingPage "2808" @default.
- W2166711075 startingPage "2801" @default.
- W2166711075 abstract "OBJECTIVE—Diabetic neuropathy is manifested either by loss of nociception (painless syndrome) or by mechanical hyperalgesia and tactile allodynia (pain in response to nonpainful stimuli). While therapies with vasodilators or neurotrophins reverse some functional and metabolic abnormalities in diabetic nerves, they only partially ameliorate neuropathic pain. The reported link between nociception and targets of the anti-inflammatory drug sulfasalazine prompted us to investigate its effect on neuropathic pain in diabetes. RESEARCH DESIGN AND METHODS—We examined the effects of sulfasalazine, salicylates, and the poly(ADP-ribose) polymerase-1 inhibitor PJ34 on altered nociception in streptozotocin-induced diabetic rats. We also evaluated the levels of sulfasalazine targets in sciatic nerves and dorsal root ganglia (DRG) of treated animals. Finally, we analyzed the development of tactile allodynia in diabetic mice lacking expression of the sulfasalazine target nuclear factor-κB (NF-κB) p50. RESULTS—Sulfasalazine completely blocked the development of tactile allodynia in diabetic rats, whereas relatively minor effects were observed with other salicylates and PJ34. Along with the behavioral findings, sciatic nerves and DRG from sulfasalazine-treated diabetic rats displayed a decrease in NF-κB p50 expression compared with untreated diabetic animals. Importantly, the absence of tactile allodynia in diabetic NF-κB p50−/− mice supported a role for NF-κB in diabetic neuropathy. Sulfasalazine treatment also increased inosine levels in sciatic nerves of diabetic rats. CONCLUSIONS—The complete inhibition of tactile allodynia in experimental diabetes by sulfasalazine may stem from its ability to regulate both NF-κB and inosine. Sulfasalazine might be useful in the treatment of nociceptive alterations in diabetic patients." @default.
- W2166711075 created "2016-06-24" @default.
- W2166711075 creator A5003935246 @default.
- W2166711075 creator A5010941476 @default.
- W2166711075 creator A5043305805 @default.
- W2166711075 creator A5046423935 @default.
- W2166711075 creator A5064834050 @default.
- W2166711075 date "2008-10-01" @default.
- W2166711075 modified "2023-10-17" @default.
- W2166711075 title "Sulfasalazine Blocks the Development of Tactile Allodynia in Diabetic Rats" @default.
- W2166711075 cites W1551486074 @default.
- W2166711075 cites W1603393469 @default.
- W2166711075 cites W1979388123 @default.
- W2166711075 cites W1981799323 @default.
- W2166711075 cites W2006770050 @default.
- W2166711075 cites W2006983951 @default.
- W2166711075 cites W2011065088 @default.
- W2166711075 cites W2011496352 @default.
- W2166711075 cites W2015438190 @default.
- W2166711075 cites W2016249383 @default.
- W2166711075 cites W2024492975 @default.
- W2166711075 cites W2035616122 @default.
- W2166711075 cites W2038250511 @default.
- W2166711075 cites W2046147455 @default.
- W2166711075 cites W2055384723 @default.
- W2166711075 cites W2067845216 @default.
- W2166711075 cites W2076390208 @default.
- W2166711075 cites W2078748170 @default.
- W2166711075 cites W2082738188 @default.
- W2166711075 cites W2086697238 @default.
- W2166711075 cites W2088291447 @default.
- W2166711075 cites W2091405455 @default.
- W2166711075 cites W2106861254 @default.
- W2166711075 cites W2115659532 @default.
- W2166711075 cites W2116522904 @default.
- W2166711075 cites W2120064316 @default.
- W2166711075 cites W2125476541 @default.
- W2166711075 cites W2127634810 @default.
- W2166711075 cites W2131840341 @default.
- W2166711075 cites W2136561424 @default.
- W2166711075 cites W2140708403 @default.
- W2166711075 cites W2142908091 @default.
- W2166711075 cites W2150069559 @default.
- W2166711075 cites W2159414724 @default.
- W2166711075 cites W2162470325 @default.
- W2166711075 cites W2162666481 @default.
- W2166711075 cites W2172201406 @default.
- W2166711075 cites W4240799972 @default.
- W2166711075 doi "https://doi.org/10.2337/db07-1274" @default.
- W2166711075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2551692" @default.
- W2166711075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18633115" @default.
- W2166711075 hasPublicationYear "2008" @default.
- W2166711075 type Work @default.
- W2166711075 sameAs 2166711075 @default.
- W2166711075 citedByCount "33" @default.
- W2166711075 countsByYear W21667110752012 @default.
- W2166711075 countsByYear W21667110752013 @default.
- W2166711075 countsByYear W21667110752014 @default.
- W2166711075 countsByYear W21667110752015 @default.
- W2166711075 countsByYear W21667110752017 @default.
- W2166711075 countsByYear W21667110752018 @default.
- W2166711075 countsByYear W21667110752020 @default.
- W2166711075 countsByYear W21667110752021 @default.
- W2166711075 countsByYear W21667110752022 @default.
- W2166711075 countsByYear W21667110752023 @default.
- W2166711075 crossrefType "journal-article" @default.
- W2166711075 hasAuthorship W2166711075A5003935246 @default.
- W2166711075 hasAuthorship W2166711075A5010941476 @default.
- W2166711075 hasAuthorship W2166711075A5043305805 @default.
- W2166711075 hasAuthorship W2166711075A5046423935 @default.
- W2166711075 hasAuthorship W2166711075A5064834050 @default.
- W2166711075 hasBestOaLocation W21667110751 @default.
- W2166711075 hasConcept C126322002 @default.
- W2166711075 hasConcept C134018914 @default.
- W2166711075 hasConcept C15490471 @default.
- W2166711075 hasConcept C170493617 @default.
- W2166711075 hasConcept C2777107010 @default.
- W2166711075 hasConcept C2777883359 @default.
- W2166711075 hasConcept C2779134260 @default.
- W2166711075 hasConcept C2779178840 @default.
- W2166711075 hasConcept C2779245659 @default.
- W2166711075 hasConcept C2779383735 @default.
- W2166711075 hasConcept C2779901536 @default.
- W2166711075 hasConcept C2780016216 @default.
- W2166711075 hasConcept C2780479503 @default.
- W2166711075 hasConcept C2781149210 @default.
- W2166711075 hasConcept C42219234 @default.
- W2166711075 hasConcept C555293320 @default.
- W2166711075 hasConcept C71924100 @default.
- W2166711075 hasConcept C98274493 @default.
- W2166711075 hasConceptScore W2166711075C126322002 @default.
- W2166711075 hasConceptScore W2166711075C134018914 @default.
- W2166711075 hasConceptScore W2166711075C15490471 @default.
- W2166711075 hasConceptScore W2166711075C170493617 @default.
- W2166711075 hasConceptScore W2166711075C2777107010 @default.
- W2166711075 hasConceptScore W2166711075C2777883359 @default.
- W2166711075 hasConceptScore W2166711075C2779134260 @default.
- W2166711075 hasConceptScore W2166711075C2779178840 @default.